1. Home
  2. PLMR vs TLX Comparison

PLMR vs TLX Comparison

Compare PLMR & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Palomar Holdings Inc.

PLMR

Palomar Holdings Inc.

HOLD

Current Price

$136.68

Market Cap

3.4B

Sector

Finance

ML Signal

HOLD

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

HOLD

Current Price

$11.93

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLMR
TLX
Founded
2013
2015
Country
United States
Australia
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.9B
IPO Year
2019
2024

Fundamental Metrics

Financial Performance
Metric
PLMR
TLX
Price
$136.68
$11.93
Analyst Decision
Buy
Strong Buy
Analyst Count
5
4
Target Price
$153.60
$21.13
AVG Volume (30 Days)
177.5K
122.3K
Earning Date
05-06-2026
08-19-2026
Dividend Yield
N/A
N/A
EPS Growth
60.04
N/A
EPS
3.51
N/A
Revenue
$875,967,000.00
N/A
Revenue This Year
$192.25
N/A
Revenue Next Year
$19.34
N/A
P/E Ratio
$38.70
$150.33
Revenue Growth
58.16
N/A
52 Week Low
$100.81
$6.28
52 Week High
$147.62
$12.48

Technical Indicators

Market Signals
Indicator
PLMR
TLX
Relative Strength Index (RSI) 57.37 55.51
Support Level $116.49 $10.12
Resistance Level $140.88 $12.35
Average True Range (ATR) 3.54 0.23
MACD 0.51 -0.06
Stochastic Oscillator 95.92 56.85

Price Performance

Historical Comparison
PLMR
TLX

About PLMR Palomar Holdings Inc.

Palomar Holdings Inc that provides property and casualty insurance products to individuals and businesses. It provides insurance products serving five categories: Earthquake, Inland Marine and Other Property, Casualty, Fronting, and Crop. Company distribute products through multiple channels, including retail agents, program administrators, wholesale brokers, and partnerships with other insurance companies. The company's Earthquake product generate high premium.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: